• Back to miR-210-3p

• Yan, Yan, et al. "Elevation of circulating miR-210-3p in high-altitude hypoxic environment." Frontiers in Physiology 7 (2016): 84.
• Bavelloni, Alberto, et al. "MiRNA-210: A current overview." Anticancer research 37.12 (2017): 6511-6521.
• Zhang, Jian, et al. "Exosome and exosomal microRNA: trafficking, sorting, and function." Genomics, proteomics & bioinformatics 13.1 (2015): 17-24.
• Cai, Haiqing, et al. "Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma." Medical oncology 30.2 (2013): 499.
• Qin, Qin, Wei Furong, and Li Baosheng. "Multiple functions of hypoxia-regulated miR-210 in cancer." Journal of Experimental & Clinical Cancer Research 33.1 (2014): 50.
• Wang, Jian, et al. "Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis." PloS one 9.2 (2014)
• Zhao, An, et al. "Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma." Experimental and molecular pathology 94.1 (2013): 115-120.
• Yoshino, Hirofumi, et al. "microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma." Oncotarget 8.13 (2017): 20881.
• Li, Guorong, et al. "Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma." Urologic Oncology: Seminars and Original Investigations. Vol. 35. No. 5. Elsevier, 2017.
• Dong, Fan, et al. "Dysregulation of miRNAs in bladder cancer: Altered expression with aberrant biogenesis procedure." Oncotarget 8.16 (2017): 27547.
• Zeng, Lili, et al. "MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia." Front Biosci (Elite Ed) 3.3 (2011): 1265-1272.
• Muralimanoharan, S., et al. "MIR-210 modulates mitochondrial respiration in placenta with preeclampsia." Placenta 33.10 (2012): 816-823.
• Dai, Yongdong, et al. "MiR-210-3p protects endometriotic cells from oxidative stress-induced cell cycle arrest by targeting BARD1." Cell death & disease 10.2 (2019): 144.
• Xu, Yawei, et al. "Seminal plasma miR‐210‐3p is a biomarker for screening dyszoospermia caused by varicocele." Andrologia (2019): e13244.